Faculty profile
Pierre Lemieux
Back to facultyResearch
Read how they describe their research on their Université Laval profile.
Latest papers
Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration.
Clinical and experimental medicine · 2024
Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial.
JAMA network open · 2022 · senior author
Evaluation of OM3-PL/FFA Pharmacokinetics After Single and Multiple Oral Doses in Healthy Volunteers.
Clinical therapeutics · 2019 · senior author
8 publications.
Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration.
Lessard-Roy A, Marchand R, Lemieux P, Masse M, Lacerte A, Carmichael PH, Laurin D
Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial.
Mozaffarian D, Maki KC, Bays HE, Aguilera F, Gould G, Hegele RA, Moriarty PM, Robinson JG, Shi P, Tur JF, Lapointe JF, Aziz S, Lemieux P, TRILOGY (Study of CaPre in Lowering Very High Triglycerides) investigators
Evaluation of OM3-PL/FFA Pharmacokinetics After Single and Multiple Oral Doses in Healthy Volunteers.
Lapointe JF, Harvey L, Aziz S, Hegele RA, Lemieux P
A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
Lapointe JF, Harvey L, Aziz S, Jordan H, Hegele RA, Lemieux P
Higher risk of neutropenia associated with piperacillin-tazobactam compared with ticarcillin-clavulanate in children.
Lemieux P, Grégoire JP, Thibeault R, Bergeron L
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Therrien F, Lemieux P, Bélanger S, Agharazii M, Lebel M, Larivière R
Anti-inflammatory potential of a malleable matrix composed of fermented whey proteins and lactic acid bacteria in an atopic dermatitis model.
Beaulieu J, Dupont C, Lemieux P
Immunomodulation by a malleable matrix composed of fermented whey proteins and lactic acid bacteria.
Beaulieu J, Dubuc R, Beaudet N, Dupont C, Lemieux P
Frequent collaborators
- Mohsen Agharazii and Marcel Lebel: 15 shared papers
- Danielle Laurin and Pierre Lemieux: 1 shared paper
- Mohsen Agharazii and Pierre Lemieux: 1 shared paper
- Marcel Lebel and Pierre Lemieux: 1 shared paper
- Prix Et Distinctions
- Medicine
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 27, 2026 from the university directory, publication records and public research funding records.